Reminders in echocardiography reports increased use of blockers in reduced left ventricular ejection fraction.

Reminders in echocardiography reports increased use of blockers in reduced left ventricular ejection fraction. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Reminders in echocardiography reports increased use of blockers in reduced left ventricular ejection fraction. Abstract Text:

S George Carruthers,S George Carruthers,S George Carruthers,

Reminders in echocardiography reports increased use of blockers in reduced left ventricular ejection fraction. Publishing Authors By Initials

SG Carruthers,SG Carruthers,SG Carruthers,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Reminders in echocardiography reports increased use of blockers in reduced left ventricular ejection fraction. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Evidence-based medicine

VOLUME: 12

Page Numbers: 185

Journal Abbreviation:

ISSN: 1473-6810

DAY: 7

MONTH: Dec

YEAR: 2007

Reminders in echocardiography reports increased use of blockers in reduced left ventricular ejection fraction. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9608386

Reminders in echocardiography reports increased use of blockers in reduced left ventricular ejection fraction. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Reminders in echocardiography reports increased use of blockers in reduced left ventricular ejection fraction. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Reminders in echocardiography reports increased use of blockers in reduced left ventricular ejection fraction.

AFFILIATION: United Arab Emirates University, Al Ain, United Arab Emirates.

Country: England

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Evid Based Med

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Reminders in echocardiography reports increased use of blockers in reduced left ventricular ejection fraction Related Publications

• 2-Alkyl-4-aryl-pyrimidine fused heterocycles as selective 5-HT2A antagonists.
• A cleavable propeptide influences Toxoplasma infection by facilitating the trafficking and secretion of the TgMIC2-M2AP invasion complex.
• A transient forward-targeting element for microneme-regulated secretion in Toxoplasma gondii.
• ATP-dependent sugar transport complexity in human erythrocytes.
• Benzylamine histamine H(3) antagonists and serotonin reuptake inhibitors.
• Broadening discussions of "safe" in hepatitis C prevention: A close-up of swabbing in an analysis of video recordings of injecting practice.
• Caveat emptor (buyer beware).
• Discussion: the history of injectable silicone fluids for soft-tissue augmentation.
• Dual serotonin transporter inhibitor/histamine H3 antagonists: development of rigidified H3 pharmacophores.
• Elderly patients with hypertension should retain 'special' status.
• Endocrine and superovulatory responses in heifers pretreated with FSH or bovine follicular fluid.
• Host cell manipulation by the human pathogen Toxoplasma gondii.
• Hyaluronidase in the office: a necessity for every dermasurgeon that injects hyaluronic acid.
• Laboratory testing of spermicidal preparation.
• Lead identification of acetylcholinesterase inhibitors-histamine H(3) receptor antagonists from molecular modeling.
• MARveling at parasite invasion.
• Mad cows, prions, and wrinkles.
• Malakoplakia: report of a case.
• Patient-reported outcomes with botulinum neurotoxin type A.
• Recent medicinal chemistry of the histamine H3 receptor.
• Reminders in echocardiography reports increased use of blockers in reduced left ventricular ejection fraction.
• Shrinking upper and lower eyelid skin with a novel radiofrequency tip.
• Some points in the diagnosis of labyrinthine vertigo and a survey of methods of treatment, medical and surgical.
• Synthesis and biological activity of piperazine and diazepane amides that are histamine H3 antagonists and serotonin reuptake inhibitors.
• The J-curve--it is clinically relevant?
• The diagnosis of late life hypogonadism.
• The evolution of botulinum neurotoxin type A for cosmetic applications.
• The organization of a community: community-based prevention of injecting drug use-related health problems.
• The paradox dividing testosterone deficiency symptoms and androgen assays: a closer look at the cellular and molecular mechanisms of androgen action.
• [Not Available.]